Acquisition Announced

Olympus acquisition of BioProtect

US$270m consideration

Announced May 2026 (approx.)

Advisers

BioProtect

Target

Financial adviser

Olympus

Acquirer

Not disclosed

Target
BioProtect
Acquirer
Olympus
Target based in
Israel
Buyer based in
Japan
Sector
Medtech
Tags
Medtech, Oncology

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.